Canaccord Genuity Group Lowers DocGo (NASDAQ:DCGO) Price Target to $1.00

DocGo (NASDAQ:DCGO) had its price objective dropped by investment analysts at Canaccord Genuity Group from $1.50 to $1.00 in a report issued on Wednesday,Benzinga reports. The firm currently has a “hold” rating on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 66.17% from the stock’s current price.

DCGO has been the topic of a number of other research reports. Needham & Company LLC reissued a “buy” rating and set a $3.00 price target on shares of DocGo in a research report on Tuesday, March 17th. Stifel Nicolaus cut their price objective on shares of DocGo from $4.00 to $2.50 and set a “buy” rating for the company in a research report on Tuesday, March 17th. Weiss Ratings restated a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $3.00 price target on shares of DocGo in a research note on Tuesday, March 17th. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $2.38.

DocGo Trading Down 1.5%

Shares of DCGO opened at $0.60 on Wednesday. DocGo has a 12 month low of $0.59 and a 12 month high of $2.79. The firm’s 50 day moving average is $0.73 and its 200-day moving average is $0.99. The stock has a market capitalization of $59.43 million, a PE ratio of -0.33 and a beta of 0.95.

Institutional Trading of DocGo

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bridgeway Capital Management LLC raised its holdings in DocGo by 3.6% in the 3rd quarter. Bridgeway Capital Management LLC now owns 370,699 shares of the company’s stock valued at $504,000 after buying an additional 12,942 shares during the last quarter. Jane Street Group LLC lifted its holdings in DocGo by 18.8% during the 1st quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock worth $226,000 after buying an additional 13,505 shares during the period. Franklin Resources Inc. grew its position in shares of DocGo by 3.0% in the 4th quarter. Franklin Resources Inc. now owns 563,983 shares of the company’s stock valued at $495,000 after buying an additional 16,637 shares during the last quarter. Empowered Funds LLC grew its position in shares of DocGo by 14.6% in the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock valued at $121,000 after buying an additional 17,607 shares during the last quarter. Finally, Cerity Partners LLC acquired a new stake in shares of DocGo in the second quarter valued at about $37,000. 56.44% of the stock is currently owned by institutional investors.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.